Toyobo and DMC Sign JDA to Advance Sustainable Chemical Solutions

Jim Flatt, CEO DMC Biotechnologies

DMC Biotechnologies, Inc. and Toyobo Co., Ltd. entered into a multi-year collaboration agreement to develop a more sustainable, fermentation-produced, high volume chemical intermediate for use in a wide range of essential materials. This partnership brings together DMC’s expertise in precision fermentation with Toyobo’s extensive chemical and biotechnology process knowledge, along with their broad access to global markets.

Continue reading

DMC Bio launched a next-generation ingredient for health-focused brands and formulators

Jim Flatt, CEO DMC Biotechnologies

DMC Biotechnologies, a leading U.S.-based biomanufacturer, launched fermented myo-inositol. This next-generation ingredient – the company says – is now available for health-focused brands and formulators seeking high-quality, naturally produced, sustainable solutions, with improved supply resilience.

Continue reading